The United States Food and Drug Administration (US FDA) has conducted an inspection at Alembic Pharmaceuticals' Injectable Facility (F-3) located at Karkhadi from 28th October, 2021 to 10th November, 2021. The USFDA issued a Form 483 with 10 observations. None of the observations are related to data integrity and management believes that they are addressable.
The Company is preparing the response to the observations, which will be submitted to the USFDA.
The Company is committed to maintain the highest quality standards and compliance at all times.
Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 793.20 as compared to the previous close of Rs. 779.85. The total number of shares traded during the day was 33842 in over 2667 trades.
The stock hit an intraday high of Rs. 804.75 and intraday low of 765.00. The net turnover during the day was Rs. 26334123.00.